IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 34
Titolo Data di pubblicazione Autore(i) File
Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers. 1-gen-1988 Sansonno, Domenico Ettore; Fiore, G; Pietropaolo, F; Avellis, D; Napoli, Nicola; Manghisi, Og
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 1-gen-1991 Fiore, G.; Napoli, Nicola; Fera, G.; Giannelli, Gianluigi; Perricci, A.; Lonero, G.; Schiraldi, O.
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 1-gen-1993 Napoli, Nicola; Fiore, G.; Fera, G.; Modugno, A.; Giannelli, Gianluigi; Manghisi, O. G.; Schiraldi, O.
Relationship between HCV serotypes and tumor focality in HCV-infected cirrhotic patients with HCC 1-gen-1997 Sacco, R; Fiore, G; Tortorella, C; Galetta, V; Marinosci, F; Papa, L; Napoli, Nicola; Schiraldi, O.
Ribavirin and high dose of interferon-alfa for retreatment of patients with chronic hepatitis C resistant to IFN alone 1-gen-1997 Napoli, Nicola; Sacco, R; Fiore, G; Piazzolla, G; Staiano, C; Lauletta, R; Loiacono, G; Giannelli, Gianluigi; Schiraldi, O.
Vasculite sistemica secondaria a trattamento con alfa-interferone in un soggetto con crioglobulinemia mista di tipo II 1-gen-1998 Perrone, A; Napoli, Nicola; Morano, Cm; Rotolo, G; Antonaci, S; Schiraldi, O.
Angiodisplasia gastrica di grave entità in un caso di porpore di Schonlein-Henoch 1-gen-1998 Napoli, Nicola; Leuci, D; Antonaci, S; Schiraldi, O.
Sierotipi del virus dell'epatite C e focalità tumorale in pazienti con cirrosi epatica HCV-correlata ed epatocarcinoma 1-gen-1998 Sacco, R; Fiore, G; Tortorella, C; Napoli, Nicola; Marinosci, F; Schiraldi, O; Antonaci, S.
Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in Chronic Hepatitis C: a critical reappraisal 1-gen-2001 Antonaci, S; Piazzolla, Giuseppina; Napoli, Nicola; Vella, Fs; Fiore, Giorgio; Schiraldi, O.
Neutrophil apoptotic cell death: does it contribute to the increased infectious risk in aging? 1-gen-2001 Tortorella, Cosimo; Piazzolla, Giuseppina; Napoli, Nicola; Antonaci, S.
Asymptomatic systemic sarcoidosis arising 5 years after IFN-alfa treatment for chronic hepatitis C: a new challenge for clinicians 1-gen-2004 Tortorella, C; Napoli, Nicola; Panella, E; Antonaci, A; Gentile, A; Antonaci, S.
Manifestazioni extraepatiche multiple in una paziente con epatite cronica C trattata con interferone-alfa 1-gen-2004 Napoli, Nicola; Tortorella, C; Deramo, Mt; Antonaci, A; Parisi, Cv; Antonaci, S.
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 1-gen-2005 Marinosci, F; Bergamini, C; Fransvea, E; Napoli, Nicola; Maurel, P; Antonaci, S; Giannelli, Gianluigi
Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C 1-gen-2005 Napoli, Nicola; Giannelli, Gianluigi; Parisi, Cv; Antonaci, A; Maddalena, G; Antonaci, S.
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin 1-gen-2005 Marinosci, F; Bergamini, C; Fransvea, E; Napoli, Nicola; Maurel, P; Dentico, Pietro; Antonaci, S; Giannelli, Gianluigi
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes 1-gen-2006 Giannelli, Gianluigi; Bergamini, C; Marinosci, F; Fransvea, E; Napoli, Nicola; Maurel, P; Dentico, Pietro; Antonaci, S.
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 1-gen-2007 Giannelli, Gianluigi; Napoli, Nicola; Antonaci, S.
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 1-gen-2007 Napoli, Nicola; Giannelli, Gianluigi; Antonaci, A; Antonaci, S.
The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response 1-gen-2008 Napoli, Nicola; Giannelli, Gianluigi; Antonaci, A.; Antonaci, S.
Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy 1-gen-2010 Simone, O; Tortorella, Cosimo; Zaccaro, B; Napoli, Nicola; Antonaci, S.
Mostrati risultati da 1 a 20 di 34
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile